Saurav Basu
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 16
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 8
-
- Medication Adherence and Compliance 15
- Co-authors
- Suneela Garg (35 shared papers)Nandini Sharma (40 shared papers)Mongjam Meghachandra Singh (22 shared papers)Amod Laxmikant Borle (9 shared papers)Charu Kohli (5 shared papers)Kamal Kishore Chopra (3 shared papers)Bratati Banerjee (8 shared papers)Pragya Sharma (15 shared papers)
- Journals
- The Lancet (13 papers)Diabetes & Metabolic Syndrome Clinical Research & Reviews (5 papers)Osong Public Health and Research Perspectives (3 papers)The Lancet Neurology (2 papers)Journal of Public Health (2 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Saurav Basu
167 papers receiving 14.6k citations
Saurav Basu's Hit Papers
Peers
Comparison fields: 5 of 193
- Applied Microbiology and Biotechnology 475
- Molecular Medicine 622
- Family Practice 122
- Endocrinology, Diabetes and Metabolism 1.0k
- Microbiology 358
Countries citing papers authored by Saurav Basu
This map shows the geographic impact of Saurav Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saurav Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saurav Basu more than expected).
Fields of papers citing papers by Saurav Basu
This network shows the impact of papers produced by Saurav Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saurav Basu. The network helps show where Saurav Basu may publish in the future.
Co-authors
The 25 scholars most cited alongside Saurav Basu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 2 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2904 |
| 3 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1851 |
| 4 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 1486 |
| 5 | The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 680 |
| 6 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 654 |
| 7 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 650 |
| 8 | Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 484 |
| 9 | Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 428 |
| 10 | Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 322 |
| 11 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 177 |
| 12 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 170 |
| 13 | Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 118 |
| 14 | 2020 | 102 | |
| 15 | 2020 | 89 | |
| 16 | Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 86 |
| 17 | Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 82 |
| 18 | Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 71 |
| 19 | Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 69 |
| 20 | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 65 |
About Saurav Basu
Saurav Basu is a scholar working on Infectious Diseases, Family Practice, Endocrinology, Diabetes and Metabolism, Epidemiology and Nutrition and Dietetics, having authored 189 papers that have together received 15.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (16 papers), Medication Adherence and Compliance (15 papers), Chronic Disease Management Strategies (12 papers), Child Nutrition and Water Access (11 papers), Global Maternal and Child Health (10 papers), SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (475 citations), Molecular Medicine (622 citations), Family Practice (122 citations), Endocrinology, Diabetes and Metabolism (1.0k citations) and Microbiology (358 citations). Saurav Basu has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Suneela Garg, Nandini Sharma, Mongjam Meghachandra Singh, Amod Laxmikant Borle, Charu Kohli, Kamal Kishore Chopra, Bratati Banerjee, Pragya Sharma, Shubhanjali Roy and Pragya Sharma. Their work appears in journals such as The Lancet, Diabetes & Metabolic Syndrome Clinical Research & Reviews, Osong Public Health and Research Perspectives, The Lancet Neurology and Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.